Hmmm. Thoughts @oncology_BG, @VPrasadMDMPH? Merck Receives Complete Response Letter From US FDA for pembrolizumab in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC) https://t.co/PNeNpSDdD1
Well said, Jimmy. That's exactly why we fought so hard for the ACA, and why we need to protect it for kids like Billy. And congratulations! https://t.co/77F8rZrD3P